Related Experiment Video
Updated: Jan 30, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Malignant Hypertension Causing a Pulmonary-Renal Syndrome
1Clinical School, University of Melbourne, Parkville, Victoria, Australia.
Malignant hypertension can mimic pulmonary-renal syndrome, a condition typically associated with autoimmune diseases. This case highlights the importance of considering severe hypertension in the differential diagnosis of acute kidney injury with respiratory symptoms.
Area of Science:
- Nephrology
- Pulmonology
- Hypertension
Background:
- Pulmonary-renal syndrome involves acute kidney injury, hematuria, and hemoptysis.
- It is often a sign of conditions like ANCA vasculitis requiring immunosuppression.
Observation:
- A patient presented with hemoptysis, acute renal failure, hematuria, and severe hypertension.
- Initial diagnosis was unclear, leading to treatment with antihypertensives, renal replacement therapy, and immunosuppression.
Findings:
- Renal biopsy revealed malignant hypertension.
- Autoantibodies were negative, ruling out typical autoimmune causes.
Implications:
- Malignant hypertension should be considered in the differential diagnosis of pulmonary-renal syndrome.
- This presentation underscores the diverse clinical manifestations of severe hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

